Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

United Airlines' Dash for Cash Comes at a Cost
United Airlines' Dash for Cash Comes at a Cost

At the end of March, United Airlines (NASDAQ: UAL) had a little over $7 billion of liquidity. Considering the rate at which airlines have been burning cash in recent months, that didn't look like

Can Nikola Succeed Where Other Alternative-Fuel Trucking Stocks Have Failed?
Can Nikola Succeed Where Other Alternative-Fuel Trucking Stocks Have Failed?

It seems like everybody's talking about Nikola (NASDAQ: NKLA) these days. The alternative-fuel trucking upstart now has a bigger market cap than Ford despite never having sold -- or even

3 Healthcare Insurance Stocks With Great Dividends and More
3 Healthcare Insurance Stocks With Great Dividends and More

With the market so volatile this year, you might need a little insurance. Investors looking for their safe place can't get much return from of a money market account, but there are healthcare

3 Top Retailers to Buy in July
3 Top Retailers to Buy in July

Most retailers just went through their worst operating stretch in decades, and there's every reason to expect further pain ahead in the second half of 2020. Economic growth might be weak, with a

4 Obstacles Standing in the Way of a Second Stimulus Check
4 Obstacles Standing in the Way of a Second Stimulus Check

Americans may be feeling hopeful about the possibility of getting more COVID-19 money as lawmakers from both sides of the aisle have expressed some support for sending out a second pandemic stimulus

3 Restaurant Stocks to Avoid in July
3 Restaurant Stocks to Avoid in July

I went over five restaurant stocks that seem appetizing for investors earlier this week, but the rising serving tray isn't lifting all publicly traded eateries. There are a few situations that you

The PPP Loan Deadline Gets a Last-Minute Extension with $130 Billion Still Unclaimed
The PPP Loan Deadline Gets a Last-Minute Extension with $130 Billion Still Unclaimed

Though the U.S. economy as a whole got hammered once COVID-19 invaded domestically, small businesses really bore the brunt of the financial hit. Earlier this year, countless local establishments

Why NVIDIA Is All Set to Break Out
Why NVIDIA Is All Set to Break Out

Advanced Micro Devices (NASDAQ: AMD) took NVIDIA (NASDAQ: NVDA) by storm in the first calendar quarter of 2020, clocking nice market share growth in the discrete graphics cards space thanks to a

3 Things Workhorse Group Stock Bulls Need to Happen Soon
3 Things Workhorse Group Stock Bulls Need to Happen Soon

Electric vehicles have been a long-held dream for many, and for investors, the right investments have been extremely lucrative. EV pioneer Tesla (NASDAQ: TSLA) came public a decade ago, and it's

Forget Vertex, Biogen Is a Better Value Stock
Forget Vertex, Biogen Is a Better Value Stock

Among pharmaceutical industry investors, Vertex Pharmaceuticals (NASDAQ: VRTX) is a broadly popular stock thanks to its impressive year-over-year quarterly earnings growth of 124.4% and its proven

Is 360 Finance a Good Stock to Consider Now?
Is 360 Finance a Good Stock to Consider Now?

China's online lending industry is out of favor presently, thanks to challenges such as regulatory uncertainties, poor sentiments toward Chinese companies, and negative impacts from the COVID-19

How to Win at Retirement, Even if There's a Second Wave
How to Win at Retirement, Even if There's a Second Wave

Imagine that your retirement lifestyle was determined by the spin of the roulette wheel. That would stink, right? You'd watch helplessly, waiting for a little ball to put in you in poverty or to

3 Reasons PayPal's Taking Share of Online Checkout
3 Reasons PayPal's Taking Share of Online Checkout

Lots of consumers have shifted their spending online amid the coronavirus pandemic. Visa and Mastercard reported 18% and 20% increases, respectively, in card-not-present spending (excluding travel)

If You Invested $1,000 in Dexcom's IPO, This Is How Much Money You'd Have Now
If You Invested $1,000 in Dexcom's IPO, This Is How Much Money You'd Have Now

Dexcom (NASDAQ: DXCM) went public on April 14, 2005. The stock opened at $12.08 a share. At that price, an investment of $1,000 would have gotten you 82 shares.

That investment would have been a

Is ONEOK Stock a Buy?
Is ONEOK Stock a Buy?

Midstream company ONEOK (NYSE: OKE) is sending out mixed signals in the face of a material energy industry downturn. With a massive 11% yield, however, it's worth taking the time to parse through

3 Reasons to Buy Canopy Growth Instead of Aurora Cannabis
3 Reasons to Buy Canopy Growth Instead of Aurora Cannabis

Year to date, shares of the two largest companies in the cannabis sector, Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB), have not been performing well. Issues with oversupply in Canada

My Top 5 Portfolio Holdings for the Second Half of 2020
My Top 5 Portfolio Holdings for the Second Half of 2020

To say that 2020 has been a challenging year for Wall Street would be a gross understatement. Thus far, the coronavirus disease 2019 (COVID-19) pandemic has cost more than 20 million people their

Love Dividends? 3 Stocks You Might Want to Buy
Love Dividends? 3 Stocks You Might Want to Buy

Savvy investors have long included dividend stocks in their portfolios as a reliable wealth accumulation tool, and eventually a foundation for steady income in retirement. Unfortunately, several

2 Biotech Stocks That Could Soar in 2020
2 Biotech Stocks That Could Soar in 2020

Stocks in the biotechnology sector have outperformed the broader market year to date. Despite the market volatility throughout this year, there are still good prospects in this sector, especially in

Is Iovance Biotherapeutics a Buy?
Is Iovance Biotherapeutics a Buy?

Cell therapies are increasingly being added to drug pipelines across the biopharmaceutical industry, but Iovance Biotherapeutics (NASDAQ: IOVA) was one of the first movers with its

Should You Throw in the Towel on Intercept Pharmaceuticals After Its Big Setback?
Should You Throw in the Towel on Intercept Pharmaceuticals After Its Big Setback?

Intercept Pharmaceuticals (NASDAQ: ICPT) fully expected approval from the Food and Drug Administration for obeticholic acid (OCA) in treating non-alcoholic steatohepatitis (NASH). CEO Mark Pruzanski

How Avid Bioservices Beat Wall Street Estimates in Q4
How Avid Bioservices Beat Wall Street Estimates in Q4

Like most stocks, Avid Bioservices (NASDAQ: CDMO) plunged earlier this year in the wake of the COVID-19 pandemic. However, the contract development and manufacturing organization (CDMO) has bounced

Better Buy: McDonald's vs. Bloomin' Brands
Better Buy: McDonald's vs. Bloomin' Brands

When picking stocks to invest in, it pays to focus on high-quality companies over a time frame long enough to let you ignore the noise. Restaurant stocks are typically tough businesses, but I think

Thinking of Claiming Social Security During COVID-19? 4 Things You Need to Know
Thinking of Claiming Social Security During COVID-19? 4 Things You Need to Know

The COVID-19 crisis has upended so many Americans' lives from a financial standpoint, and that includes older workers who are grappling with unemployment and income loss. If the pandemic has caused

3 Things You Need to Know About Index Funds and ETFs
3 Things You Need to Know About Index Funds and ETFs

Those of us who have invested directly in stocks know very well the sense of anxiety that comes along with it. Though we all know the importance of patience and perseverance when it comes to